Tag
LON: GSK
- Allarity Therapeutics announces stenoparib dosing patent into 2045
- Enanta Pharmaceuticals starts late-stage RSV trial with 2027 data due
- Arbutus Biopharma says FDA lifts AB‑101 clinical hold
- GSK wins FDA approval for Hibsago in chronic hepatitis B
- Wave Life Sciences brings big biotech breakthrough with RNA editing therapy